[HTML][HTML] Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
L Peter, DJ Wendering, S Schlickeiser… - … Therapy-Methods & …, 2022 - cell.com
Solid organ transplant (SOT) recipients receive therapeutic immunosuppression that
compromises their immune response to infections and vaccines. For this reason, SOT …
compromises their immune response to infections and vaccines. For this reason, SOT …
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients.
L Peter, DJ Wendering, S Schlickeiser… - … therapy. Methods & …, 2022 - europepmc.org
Solid organ transplant (SOT) recipients receive therapeutic immunosuppression that
compromises their immune response to infections and vaccines. For this reason, SOT …
compromises their immune response to infections and vaccines. For this reason, SOT …
[HTML][HTML] Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
L Peter, DJ Wendering, S Schlickeiser… - … Therapy. Methods & …, 2022 - ncbi.nlm.nih.gov
Solid organ transplant (SOT) recipients receive therapeutic immunosuppression that
compromises their immune response to infections and vaccines. For this reason, SOT …
compromises their immune response to infections and vaccines. For this reason, SOT …
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
L Peter, DJ Wendering, S Schlickeiser… - … Therapy. Methods & …, 2022 - publications.hereon.de
Solid organ transplant (SOT) recipients receive therapeutic immunosuppression that
compromises their immune response to infections and vaccines. For this reason, SOT …
compromises their immune response to infections and vaccines. For this reason, SOT …
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
L Peter, DJ Wendering… - … therapy. Methods & …, 2022 - pubmed.ncbi.nlm.nih.gov
Solid organ transplant (SOT) recipients receive therapeutic immunosuppression that
compromises their immune response to infections and vaccines. For this reason, SOT …
compromises their immune response to infections and vaccines. For this reason, SOT …
[HTML][HTML] Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
L Peter, DJ Wendering, S Schlickeiser… - … Therapy-Methods & …, 2022 - Elsevier
Solid organ transplant (SOT) recipients receive therapeutic immunosuppression that
compromises their immune response to infections and vaccines. For this reason, SOT …
compromises their immune response to infections and vaccines. For this reason, SOT …
[HTML][HTML] Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
L Peter, DJ Wendering, S Schlickeiser… - … Therapy-Methods & …, 2022 - cell.com
Solid organ transplant (SOT) recipients receive therapeutic immunosuppression that
compromises their immune response to infections and vaccines. For this reason, SOT …
compromises their immune response to infections and vaccines. For this reason, SOT …
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients.
L Peter, DJ Wendering, S Schlickeiser… - … therapy. Methods & …, 2022 - europepmc.org
Solid organ transplant (SOT) recipients receive therapeutic immunosuppression that
compromises their immune response to infections and vaccines. For this reason, SOT …
compromises their immune response to infections and vaccines. For this reason, SOT …